Menu
WAPPS-Hemo is pleased to announce that Altuviiio™ is now available!
We are pleased to announce that the concentrate Altuviiio™ (also named BIVV001), newly approved by FDA, was added on the WAPPS-Hemo platform.
The WAPPS-Hemo Team - Apr 14, 2023
View this WAPPS News Article
The WAPPS-Hemo Team - Jun 13, 2022
View this WAPPS News Article
The WAPPS-Hemo Team - Sep 1, 2020
WAPPS-Hemo is pleased to announce the launch of two new population pharmacokinetic (PK) models for ESPEROCT® (Antihemophilic Factor VIII (Recombinant, B-Domain Truncated), PEGylated) that use the one-stage and chromogenic assays.
The WAPPS-Hemo Team - Jun 11, 2020
Looking for an opportunity to participate in a clinical trial for WAPPS? There are currently two trials that are recruiting.
The WAPPS-Hemo Team - Apr 17, 2020
Currently available PK models in WAPPS-Hemo. New models are added when sufficient data has been collected.
The WAPPS-Hemo Team - Apr 2, 2020
Publications by the core WAPPS-Hemo team, the WAPPS-Hemo Research Network and other related publication sources.
The WAPPS-Hemo Team - Mar 10, 2020
We have been receiving questions regarding Afstyla and whether WAPPS-Hemo already multiplies the resultant measurements by a factor of 2 if a one-stage clotting assay was used. Conversely, the scientific community recommends the use of chromogenic assays or to “calibrate” the clotting assays with a specific standard.
The WAPPS-Hemo Team - Mar 12, 2019
If you have any WAPPS-Hemo related research or news items you would like to share, please contact us
© 2024 Copyright WAPPS-Hemo